Allstate Corp Abbott Laboratories Transaction History

Allstate Corp

$1.02 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $43,515 - $48,574	-432 Reduced 7.83%	5,082 $528,000
Q1 2024 May 10, 2024	SELL	$109.52 - $120.96 $41,946 - $46,327	-383 Reduced 6.49%	5,514 $626,000
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $65,928 - $80,702	-731 Reduced 11.03%	5,897 $649,000
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $29,629 - $33,013	-294 Reduced 4.25%	6,628 $722,000
Q1 2023 May 10, 2023	SELL	$96.86 - $114.01 $6.04 Million - $7.11 Million	-62,362 Reduced 90.01%	6,922 $700,000
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $2.03 Million - $2.38 Million	21,345 Added 44.53%	69,284 $7.61 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $887,869 - $1.03 Million	-9,176 Reduced 16.07%	47,939 $4.64 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $222,818 - $269,316	2,183 Added 3.97%	57,115 $6.21 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $9.89 Million - $12.1 Million	-86,747 Reduced 61.23%	54,932 $6.5 Million
Q4 2021 Feb 15, 2022	BUY	$115.53 - $141.46 $10.7 Million - $13.2 Million	92,970 Added 190.87%	141,679 $19.9 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $425,459 - $470,681	-3,647 Reduced 6.97%	48,709 $5.75 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $356,512 - $419,666	-3,370 Reduced 6.05%	52,356 $6.07 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $373,865 - $440,470	3,435 Added 6.57%	55,726 $6.68 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $160,755 - $175,177	1,531 Added 3.02%	52,291 $5.73 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $486,608 - $590,949	-5,310 Reduced 9.47%	50,760 $5.52 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $394,335 - $504,700	-5,150 Reduced 8.41%	56,070 $5.13 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $6.7 Million - $9.8 Million	-106,636 Reduced 63.53%	61,220 $4.83 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $1,413 - $1,573	18 Added 0.01%	167,856 $14.6 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $583,519 - $632,716	-7,130 Reduced 4.08%	167,838 $14 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $1.96 Million - $2.28 Million	26,865 Added 18.14%	174,968 $14.7 Million
Q1 2019 May 20, 2019	BUY	$66.22 - $80.06 $72,842 - $88,066	1,100 Added 0.75%	148,103 $11.8 Million
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $9.64 Million - $10.9 Million	147,003 New	147,003 $10.6 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.4 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.03 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.74 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.28 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.

Account